Pharma Innovators

Even before the COVID-19 pandemic, HCPs were increasingly relying on digital channels to stay up-to-date in the healthcare industry.

I recently chatted with Regina Paris, VP of Engagement Strategy at Evoke, to discuss how brands are shifting to (and embracing) the vast opportunities of digital outreach, why qualified data sources are so imperative for achieving optimal engagement, and what is unique about HCPs’ digital behavior in the rare disease space.

The full text of our conversation is below.

I recently spoke with Jane Portman, SVP, General Manager, Merkle Health, to discuss new sales and marketing trends within the pharmaceutical industry--particularly a focus on an increasing “virtual” space in which sales reps are forced to operate. We also talked about why 1:1 marketing is even more critical for pharma brands now, and will be in the future.

The full text of our conversation is below.

I recently spoke with Jon Bigelow, Executive Director for the Coalition for Healthcare Communication (CHC), about the importance of advocating for the First Amendment rights of pharma manufacturers and their agencies, as well as how data privacy regulation is changing the future of healthcare communications.                                                                                                                                                                                                                                                         _{3D graphics image by Quince Creative}         

The abbreviated interview was posted on our blog. The full text of our conversation is below.

I recently spoke with Serge Loncar, Founder and CEO of CareSpeak Communications, about the value in today’s marketplace of providing patients with an effortless way to manage their health using an advanced SMS platform like CareSpeak. We also discussed how this helps to achieve better outcomes by engaging patients and caregivers, improving medication compliance, and assisting with care coordination.